SCHEDULE 13G/A: AWM Investment Company Reports 5.7% Beneficial Ownership in Clene Inc. Through Warrants

AWM Investment Company, Inc. has filed an amended Schedule 13G, reporting a 5.7% beneficial ownership stake in Clene Inc. as of December 31, 2024, primarily through warrants.

Summary

• AWM Investment Company, Inc. (AWM) filed an Amendment No. 2 to its Schedule 13G regarding its beneficial ownership in Clene Inc.
• As of December 31, 2024, AWM beneficially owns 500,000 shares of Clene Inc. Common Stock, representing 5.7% of the class.
• AWM is the investment adviser to Special Situations Cayman Fund, L.P. (CAYMAN), Special Situations Fund III QP, L.P. (SSFQP), and Special Situations Life Sciences Fund, L.P. (SSLS), collectively referred to as the Funds.
• The beneficial ownership is primarily derived from warrants held by these funds: 5,382,426 warrants for SSFQP (to purchase 269,121 shares), 1,617,574 warrants for CAYMAN (to purchase 80,879 shares), and 3,000,000 warrants for SSLS (to purchase 150,000 shares).
• These warrants can only be exercised to the extent that the total number of Common Shares then beneficially owned does not exceed 9.99% of the outstanding shares.
• AWM holds sole voting and investment power over these warrants, but holds 0 shares of Common Stock directly.
• David M. Greenhouse and Adam C. Stettner are controlling principals of AWM and members of the general partners of the Funds.

Sentiment

Score: 6

Explanation: The document is a routine Schedule 13G filing disclosing beneficial ownership. It indicates continued institutional interest in Clene Inc. by AWM Investment Company, which can be seen as a positive signal. However, it does not contain new operational or financial performance information, so the sentiment is largely neutral with a slight positive tilt due to the presence of a significant institutional investor.

Positives

• AWM Investment Company, a notable investment adviser, maintains a significant beneficial ownership stake (5.7%) in Clene Inc., indicating continued institutional investor interest.
• The holding of warrants provides potential upside exposure to Clene Inc.'s stock performance without immediate dilution from common stock ownership.

Negatives

• The beneficial ownership is primarily through warrants, not direct common stock, which means the investor does not currently hold voting power over common shares.
• The exercise of warrants is capped at 9.99% of outstanding shares, limiting the potential for AWM to increase its direct ownership beyond this threshold through these specific warrants.

Risks

• The value of the warrants is dependent on the future stock price of Clene Inc.; if the stock price does not increase sufficiently, the warrants may not be exercised or may lose value.
• The 9.99% exercise limitation on warrants could restrict AWM's ability to fully convert its warrant holdings into common stock if it would exceed this threshold, potentially impacting liquidity or strategic flexibility.

Future Outlook

This filing is a disclosure of current beneficial ownership and does not contain forward-looking statements or guidance from Clene Inc. or AWM Investment Company regarding future performance or strategic plans.

Management Comments

• Adam Stettner, Executive Vice President of AWM Investment Company, Inc., certified that the securities were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities.

Industry Context

This filing indicates continued institutional investor interest in Clene Inc., a company likely in the life sciences or biotechnology sector given the 'Life Sciences Fund' mentioned. Such filings are routine disclosures of significant ownership stakes by investment firms, providing transparency on major shareholders.

Comparison to Industry Standards

• This is a standard Schedule 13G filing, which is a regulatory requirement for investors acquiring more than 5% beneficial ownership in a public company.
• The beneficial ownership of 5.7% is a significant stake for an institutional investor, often signaling a long-term investment perspective, especially when held through warrants.
• There are no specific comparable companies, projects, or results mentioned in this filing to provide a detailed comparison of industry-specific performance or metrics.

Stakeholder Impact

• Shareholders: Provides transparency on a significant institutional holder's stake, which can influence investor confidence. The presence of a large warrant holder could imply potential future dilution if warrants are exercised, though this is capped.
• Company Management: Awareness of a significant institutional investor and its holdings.

Key Dates

Keywords

SEC filing, Schedule 13G, beneficial ownership, Clene Inc., AWM Investment Company, warrants, institutional ownership, investment adviser, common stock, equity